Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
European operations' revenue grew 58.4% to Rs 599.7 crore
European operations' revenue grew 58.4% to Rs 599.7 crore
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Total transaction value of the divestment is Rs. 3,660 million
This product will be manufactured at Lupin’s Pithampur facility in India
This product will be manufactured at Lupin's Nagpur facility in India
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The initiative will focus on advocating for cleaner air
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
RHTC will address a long-standing healthcare access issue for all the local population
Subscribe To Our Newsletter & Stay Updated